Acupuncture and Moxibustion for IBS-D

New research into Diarrhea-predominant Irritable Bowel Syndrome (IBS-D) highlights the critical role of gut microbiota in both the development and recovery of the condition. A study using an IBS-D model compared acupuncture, moxibustion, and pharmacotherapy, specifically focusing on the single acupoint Zusanli (ST 36). The findings revealed that both acupuncture and moxibustion effectively restored normal bowel function and significantly rebalanced microbial communities compared to disease-only groups.Notably, the two modalities produced distinct microbial effects: acupuncture was superior in improving colonic transit time, while moxibustion best restored stool pellet counts. Furthermore, acupuncture and moxibustion promoted a better-organized microbiota network than pharmaceutical intervention, which actually caused greater network disruption. These results provide a scientific basis for using ST 36 as a primary treatment for IBS-D. For practitioners, this suggests that tailoring the modality to the specific presentation of the patient can optimize the restoration of a resilient gut ecosystem.